Biotech news
Biotech
US-based Locus Biosciences has announced it will license its CRISPR-Cas3 technology to Janssen, a subsidiary of American pharmaceutical company Johnson & Johnson, in a deal worth a potential $818 million. 9 January 2019
Americas
Los Angeles-based law firm Pierce Bainbridge Beck Price & Hecht has hired two partners to its New York office. 9 January 2019
Asia
The Supreme Court of India has ruled that biotechnology company Monsanto’s patent for genetically modified cotton seeds is valid and enforceable in the country. 8 January 2019
Americas
Ariosa Diagnostics, a subsidiary of Swiss healthcare firm Roche, has won a patent dispute with American biotechnology firm Illumina. 2 January 2019
Americas
John Zurawski has joined Ballard Spahr as a partner in Philadelphia, after spending more than two years at McCarter & English. 19 December 2018
Biotech
Pfizer and Seattle-based biotech company Kineta Immuno-Oncology have signed a research and licensing agreement worth a potential $520 million. 18 December 2018
Americas
Holland & Hart has added Rachel Carnaggio, of counsel, to its Denver office in Colorado. 17 December 2018
Biotech
ERS Genomics has signed a deal with Swiss company Lonza Pharma & Biotech to provide access to CRISPR/Cas9 technology. 14 December 2018
Pharma
France-based biotechnology company genOway has acquired the exclusive global rights to German pharmaceutical company Merck Group’s CRISPR patents, to be used in the production and sale of rodent models. 13 December 2018
Biotech
SPCs and trade secrets are just two issues set to be discussed at C5’s 11th Pharma & Biotech Patent Litigation, on February 26 and 27 in Amsterdam. LSIPR reports. 13 December 2018